
European Modular Education and Training Programme in Safety Sciences for Medicines
27-04-2017
Funding: The project is receiving support from the Innovative Medicines Initiative Joint Undertaking, resources of which are composed of financial contribution from the EU's 7th Framework Programme and EFPIA companies.
Timeline: 2012-2017
Description: SafeSciMET has established a new and unique pan-European education and training network, providing master’s level courses in safety sciences for medicines. The training has focus on holistic, integrative and translational approaches.
Biopeople's role:
Couse Director. Biopeople / University of Copenhagen is involved in the training course concerning regulatory aspects of safety sciences.
Project Partners:
- VU University Amsterdam
- University of Konstanz
- University of Surrey
- EUFEPS
- Uppsala University
- University of Copenhagen
- Universiteit Leiden
- Universite de Lorraine
- Martin-Luther-University
- HalleKarolinska Institutet Stockholm
- University of Vienna
- Universite de Paris-Sud
- MRC Centre for Drug Safety Science
- Universidade de Lisboa
- Charite University Medicine Berlin
- Almirall
- AstraZeneca Ltd
- Bayer-Schering Pharma AG
- Boehringer-Ingelheim Pharma
- Eli-Lilly Ltd
- GlaxoSmithKline Ltd
- F. Hoffmann-La Roche
- Lundbeck A/S
- Merck KGaA
- Novartis Pharma AG
- Novo Nordisk A/S
- Orion Pharma
- Sanofi
- UCB Pharma S.A.
Biopeople is co-funded by the Ministry of Higher Education and Science, Denmark.
